 |
 |
| Last Updated: 08 Dec 2023 17:02 ET |
| Volume | Value | Traded | Advances | Declines |
| 691,820 | 39,522 | 26 | 7 | 3 |
|
|
 |
Largest net decrease in price from previous close.*
 Company Information
|
| |
| Last Updated: 08 Dec 2023 19:29 ET |
|
| | Symbol | Price | $ Chng | %Chng | Volume |
| RUN.H | 0.00500 | -0.00500 | -50.00 | 10,000 |
| NMG.H | 0.00500 | -0.00500 | -50.00 | 48,000 |
| JPWR.H | 0.02500 | -0.00500 | -16.67 | 17,600 |
|
* The previous close is the closing value for the last day the equity traded.
For example, an inactive stock's previous close may have been from a few days ago.
Stocks that trade in $US have not been converted to $CDN in the above tables. Notes and debentures are also not included in the tables. |
| |
| Company Name: | Advanced Proteome Therapeutics Corporation |
| Industry: | Scientific Research And Development Services |
Symbols/
Instruments: |
| APC.H | -Advanced Proteome Therapeutics Corporation |
|
Date of
Listing: | 14 Sep 1989 |
| Fiscal Year-end: | JUL 31 |
| Trading Status: | SUSPENDED |
| Address: | Unit 104, 8337 Eastlake Drive
Burnaby,
V5A 4W2
Canada
|
| Phone: | 1(604) 690-3797 |
Email
Address: | paul@conation.ca |
Senior
Executive: | William John (Bill) Dickie, President |
Listed companies wishing to update their information
should click here.
|
|
|
| Info TSX Venture is a comprehensive database of information on NEX listed companies, including: |
|
|
|
|
| |
